Trial | NCT00130858  Report issue

Official Title

a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    90
Phase II Study to evaluate the response on two blocks of topotecan and carboplatin
Phase II study for patients with chemosensible soft tissue sarcoma stage IV in children and adolescents ; response according to RECIST criteria following two blocks of combination therapy consisting of Topotecan and carboplatin
Study Started
Jan 31
2005
Primary Completion
Dec 31
2007
Study Completion
Mar 31
2009
Last Update
Apr 02
2009
Estimate

Drug Topotecan

Drug Carboplatin

Criteria 

Inclusion Criteria:

Soft tissue sarcoma chemosensible, stage IV
age < 21
measurable tumor lesions

Exclusion Criteria:

Lack of cooperation by the patient
no willingness of follow-up examinations
participation on another clinical trial at the same time
death due to the sickness within four weeks
No Results Posted